Clinical Trial Update: A Study to Learn About How a New Pneumococcal Vaccine Works in Infants [Phase 2]

View source ↗

Summary

Pfizer is conducting a Phase 2 study to evaluate how a new pneumococcal vaccine works in infants; the study is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• Pfizer pneumococcal vaccine (pneumococcal conjugate vaccine)

Snippet

Sponsor: Pfizer | Conditions: Pneumococcal Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING